Geode Capital Management, LLC Applied Therapeutics Inc. Transaction History

Geode Capital Management, LLC

$1.26 Trillion
Q4 2024

A detailed history of Geode Capital Management, LLC transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Geode Capital Management, LLC holds 2,084,142 shares of APLT stock, worth $1.06 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,084,142

Previous 2,091,669 0.36%

Holding current value

$1.06 Million

Previous $17.8 Million 90.04%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$0.82 - $10.24 $6,172 - $77,076	-7,527 Reduced 0.36%	2,084,142 $1.77 Million
Q3 2024 Nov 12, 2024	SELL	$4.35 - $8.5 $31,085 - $60,741	-7,146 Reduced 0.34%	2,091,669 $17.8 Million
Q2 2024 Aug 09, 2024	BUY	$4.04 - $6.37 $6.04 Million - $9.52 Million	1,494,387 Added 247.24%	2,098,815 $9.8 Million
Q1 2024 May 13, 2024	BUY	$2.25 - $7.4 $60,203 - $198,001	26,757 Added 4.63%	604,428 $4.11 Million
Q4 2023 Feb 13, 2024	BUY	$1.84 - $3.35 $246,926 - $449,566	134,199 Added 30.26%	577,671 $1.94 Million
Q3 2023 Nov 13, 2023	BUY	$1.26 - $2.77 $3,738 - $8,218	2,967 Added 0.67%	443,472 $1.1 Million
Q2 2023 Aug 11, 2023	BUY	$0.77 - $1.8 $61,158 - $142,968	79,427 Added 22.0%	440,505 $563,000
Q4 2022 Feb 13, 2023	BUY	$0.54 - $1.12 $15,666 - $32,493	29,012 Added 8.74%	361,078 $274,000
Q3 2022 Nov 14, 2022	BUY	$0.86 - $1.55 $145,875 - $262,915	169,623 Added 104.42%	332,066 $308,000
Q2 2022 Aug 12, 2022	SELL	$0.76 - $2.64 $95,370 - $331,285	-125,487 Reduced 43.58%	162,443 $154,000
Q1 2022 May 13, 2022	SELL	$1.48 - $6.22 $22,663 - $95,246	-15,313 Reduced 5.05%	287,930 $607,000
Q4 2021 Feb 11, 2022	SELL	$8.77 - $18.29 $112,703 - $235,044	-12,851 Reduced 4.07%	303,243 $2.71 Million
Q3 2021 Nov 12, 2021	BUY	$13.54 - $22.06 $340,855 - $555,338	25,174 Added 8.65%	316,094 $5.25 Million
Q2 2021 Aug 13, 2021	BUY	$14.05 - $25.04 $491,089 - $875,223	34,953 Added 13.66%	290,920 $6.05 Million
Q1 2021 May 12, 2021	BUY	$16.57 - $28.65 $1.1 Million - $1.9 Million	66,479 Added 35.08%	255,967 $4.8 Million
Q4 2020 Feb 12, 2021	BUY	$15.44 - $24.23 $303,550 - $476,361	19,660 Added 11.58%	189,488 $4.17 Million
Q3 2020 Nov 13, 2020	BUY	$19.43 - $35.36 $75,932 - $138,186	3,908 Added 2.36%	169,828 $3.53 Million
Q2 2020 Aug 13, 2020	BUY	$29.41 - $51.23 $1.15 Million - $2.01 Million	39,224 Added 30.96%	165,920 $6 Million
Q1 2020 May 14, 2020	BUY	$19.54 - $55.47 $1.15 Million - $3.27 Million	58,946 Added 87.01%	126,696 $4.14 Million
Q4 2019 Feb 13, 2020	BUY	$10.16 - $28.14 $443,321 - $1.23 Million	43,634 Added 180.93%	67,750 $1.85 Million
Q3 2019 Nov 12, 2019	BUY	$8.08 - $10.99 $194,857 - $265,034	24,116 New	24,116 $265,000

Others Institutions Holding APLT

# of Institutions

130

Shares Held

112M

Call Options Held

1.1M

Put Options Held

800K

View Full List

About Applied Therapeutics Inc.

Ticker APLT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,020,700
Market Cap $24.5M
Description
Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...

More about APLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Applied Therapeutics Inc. Transaction History